Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:liver lesion measurement
go back to main search page
Accession:CMO:0001065 term browser browse the term
Definition:Measurement of a lesion in the liver, the large, dark-red organ located in the cranial portion of the abdomen of vertebrates, just behind or below the diaphragm, that secretes bile and is active in the formation of certain blood proteins, in the metabolism of carbohydrates, fats, and proteins and in the detoxification of noxious substances. A lesion is a localized pathological change in structure of an organ or tissue due to injury or disease; especially one that is circumscribed and well defined.
Synonyms:related_synonym: hepatic lesion measurement


show annotations for term's descendants           Sort by:
area of individual liver tumorous lesion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar6 Hepatocarcinoma resistance QTL 6 IDA RGD PMID:10850431 RGD:619609
liver nonremodeling tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar14 Hepatocarcinoma resistance QTL 14 IDA RGD PMID:15185337 RGD:737884 NCBI chr18:51,464,733...83,218,561 JBrowse link
liver nonremodeling tumorous lesion volume to total liver volume ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar13 Hepatocarcinoma resistance QTL 13 IDA RGD PMID:15185337 RGD:737884 NCBI chr 4:1...32,584,199 JBrowse link
Q Hcas6 Hepatocarcinoma susceptibility QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr14:39,057,237...83,368,335 JBrowse link
Q Hcas7 Hepatocarcinoma susceptibility QTL 7 IDA RGD PMID:15185337 RGD:737884 NCBI chr15:2,266,368...46,921,453 JBrowse link
liver remodeling tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 IDA RGD PMID:15185337 RGD:737884 NCBI chr 2:1...41,244,106 JBrowse link
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:1...42,356,786 JBrowse link
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:59,874,408...85,581,182 JBrowse link
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:74,862,117...85,581,182 JBrowse link
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 IDA RGD PMID:12672032 RGD:629574 NCBI chr 7:34,293,282...79,293,282 JBrowse link
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 IDA RGD PMID:12672032 RGD:629574 NCBI chr 1:233,948,574...260,522,016 JBrowse link
liver tumorous lesion area to total liver area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:70,808,386...115,808,386 JBrowse link
Q Hcar8 Hepatocarcinoma resistance QTL 8 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:123,143,783...168,143,783 JBrowse link
liver tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar10 Hepatocarcinoma resistance QTL 10 IDA RGD PMID:12154055 RGD:629566 NCBI chr 8:40,713,066...82,925,667 JBrowse link
Q Hcar11 Hepatocarcinoma resistance QTL 11 IDA RGD PMID:12154055 RGD:629566 NCBI chr 6:82,523,650...110,548,006 JBrowse link
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA RGD PMID:15771619 RGD:1358145 NCBI chr 1:153,136,852...260,522,016 JBrowse link
Q Hcar5 Hepatocarcinoma resistance QTL 5 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:214,537,555...226,660,468 JBrowse link
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:70,808,386...115,808,386 JBrowse link
Q Hcas2 Hepatocarcinoma susceptibility QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 1:5,925,874...115,540,829 JBrowse link
Q Hcas5 Hepatocarcinoma susceptibility QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr 1:176,426,412...257,976,495 JBrowse link
Q Hcas8 Hepatocarcinoma susceptibility QTL 8 IDA RGD PMID:17079458 RGD:1599590 NCBI chr16:1...22,477,621 JBrowse link
liver tumorous lesion number to liver area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar4 Hepatocarcinoma resistance QTL 4 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:193,422,268...214,537,671 JBrowse link
liver tumorous lesion volume to total liver volume ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcas1 Hepatocarcinoma susceptibility QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr 7:91,412,594...129,807,172 JBrowse link
Q Hcas3 Hepatocarcinoma susceptibility QTL 3 IDA RGD PMID:12154055 RGD:629566 NCBI chr 1:144,267,353...222,987,745 JBrowse link
volume of individual liver tumorous lesion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar1 Hepatocarcinoma resistance QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr10:6,154,182...15,990,232 JBrowse link
Q Hcar12 Hepatocarcinoma resistance QTL 12 IDA RGD PMID:12154055 RGD:629566 NCBI chr 3:29,463,235...118,376,539 JBrowse link
Q Hcar2 Hepatocarcinoma resistance QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 4:78,878,504...123,878,504 JBrowse link
Q Hcar3 Hepatocarcinoma resistance QTL 3 IDA RGD PMID:10493520 RGD:619598 NCBI chr 8:54,237,644...99,103,503 JBrowse link
Q Hcar9 Hepatocarcinoma resistance QTL 9 IDA RGD PMID:12154055 RGD:629566 NCBI chr 4:109,866,907...167,139,601 JBrowse link
Q Hcas4 Hepatocarcinoma susceptibility QTL 4 IDA RGD PMID:12154055 RGD:629566 NCBI chr16:4,227,609...46,975,965 JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        liver lesion measurement 29
          liver non-tumorous lesion measurement + 0
          liver tumorous lesion measurement + 29
paths to the root